Patient Reported Outcomes at Cancer Care Ontario: The ...
Transcript of Patient Reported Outcomes at Cancer Care Ontario: The ...
![Page 1: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/1.jpg)
Patient Reported
Outcomes at Cancer Care
Ontario: The program, the
data, the research
DR. LISA BARBERA SEPTEMBER 19, 2017 UNC
![Page 2: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/2.jpg)
Objectives
2
1. To describe the Patient Reported Outcome (PRO) Program at
Cancer Care Ontario (CCO)
2. To describe how this is being used to drive quality of care
3. To describe how the data has been used in research
![Page 3: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/3.jpg)
Patient Reported Outcome Measures (PROMs)
3
A Patient Reported Outcome (PRO) is a
validated measure that provides a
comprehensive picture on the impact of cancer
and treatment from the patient perspective.
By tailoring the focus on physical symptoms
and psychosocial concerns that are relevant to
the patient, PROs help the healthcare team
deliver care that is more person-centred,
responsive and efficient.
PROs are administered electronically at a
computer station, on a mobile device or by
paper and pencil.
![Page 4: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/4.jpg)
Paradigm shift
4
Physician knows best
Providing services
Survival
Person centred care
Symptom management
Quality of life
Patient experience
![Page 5: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/5.jpg)
5
What is CCO?
![Page 6: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/6.jpg)
Vision Working together to create the best
health systems in the world.
Mission Together, we will improve the
performance of our health systems
by driving quality, accountability,
innovation and value.
![Page 7: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/7.jpg)
• Agency of the government accountable to the provincial ministry of
health
• Provincial government’s advisor on the cancer system and access to
key services
• leads multi-year system planning
• contracts for services with hospitals and providers
• deploys information systems
• establishes guidelines and standards
• tracks performance targets
What is Cancer Care Ontario?
![Page 8: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/8.jpg)
What is Cancer Care Ontario?
8
• Ontario population is ~14M
![Page 9: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/9.jpg)
9
CCO
Screening and Prevention
Clinical Programs and Quality Initiatives
Drugs Quality Diagnosis and
Treatment Patient
Centred Care
Nursing
Patient Education
PSO
PREMS
PROs
Primary care, palliative care, survivorship
![Page 10: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/10.jpg)
10
![Page 11: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/11.jpg)
11
![Page 12: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/12.jpg)
12
What is the CCO PRO Program?
![Page 13: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/13.jpg)
Over the years: Ontario’s Progress in Patient Reported Outcomes and Symptom Management
13
• Palliative care
program
established
• Symptom
management
identified as a gap
• ESAS introduced
• ISAAC released–
the electronic
engine for
standardized
symptom
assessment
• Psychosocial Oncology program
established
• Clinician symptom management
tools/guides developed
• The PHQ-9 and GAD-7 identified
by CCO’s PROs Working Group
(2012)
• Second PRO introduced: Patient
Reported Functional Status (Patient
ECOG)
• Patient-Reported Outcomes Advisory
Committee formed (2013)
• Pilot projects launched (2014)
• EPIC
• iPEHOC
• Clinical lead for PRO program
2005-2006 2007 2013-2015 2008 - 2012 2016-2019
• Program Strategic
Framework to guide
work
• EPIC
implementation
![Page 14: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/14.jpg)
![Page 15: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/15.jpg)
![Page 16: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/16.jpg)
![Page 17: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/17.jpg)
![Page 18: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/18.jpg)
![Page 19: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/19.jpg)
![Page 20: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/20.jpg)
![Page 21: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/21.jpg)
Your Symptoms Matter Stats
78 Partner Sites
14 Regional Cancer Centers
Where is symptom screening happening? What is the volume of surveys in ISAAC?
6,733,903 total surveys (includes ESAS,
PRFS, and PPS)
3,812,156 ESAS surveys 551,290
unique patients
What are the most common symptoms?
75% 71% 50%
Tiredness or fatigue Issues of wellbeing Depression
What do patients report?
83% of patients
reported that their
health team
treats/manages
their physical
symptoms
78% of patients
reported that their
health team
responds to their
worries, concerns,
or feelings of
sadness
86% of patients
reported that their
health team
includes them in
decisions about
how to
treat/manage their
symptoms
28 sites use
EMR
integration
![Page 22: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/22.jpg)
22
![Page 23: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/23.jpg)
Methods for creating the Strategic Framework
Collected data from numerous sources: • Extensive document review • Interviews with key informants • Strategic planning workshop with multiple
stakeholders
First draft was shared with key stakeholders to capture a unified vision: • Patient and Family Advisors (PFAs) • Ontario Collaborative for Symptom Management
Committee
Framework is well aligned with PFA vision and goals for program
Strategic Framework
![Page 24: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/24.jpg)
Strategic Framework
24
![Page 25: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/25.jpg)
Strategic Framework
25
![Page 26: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/26.jpg)
PROs and Symptom Management in Ontario
Strategic Framework
26
![Page 27: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/27.jpg)
Pipeline
27
![Page 28: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/28.jpg)
Pipeline – EPIC (prostate cancer)
28
EPIC Project
![Page 29: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/29.jpg)
EPIC-CP Background and Context
29
• Currently, ESAS-r is being used in cancer centres as the standard for symptom screening to
inform clinical care
• While ESAS-r is a useful tool for generic symptom screening, it does not capture
disease-specific concerns or the effects of specific treatments
• EPIC was selected to address the unique needs of men with prostate cancer
• EPIC-CP is a 16-item instrument specifically designed for men with prostate cancer that
measures symptoms such as:
Urinary incontinence
Urinary irritation
Bowel incontinence
Sexual health dysfunction
Hormonal
Health-Related Quality of Life (HRQOL)
![Page 30: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/30.jpg)
30
EPIC Phase I Pilot
• Conducted in 2012 to test the long-form EPIC measure (26 items) for feasibility and
acceptability in one Ontario cancer centre (Kingston)
• Results indicated that:
• EPIC was endorsed and accepted by both patients and clinicians in radiation review
clinics,
• and that the prostate-specific domains of EPIC were seen as a strength
![Page 31: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/31.jpg)
EPIC-CP Phase II Pilot
31
• In 2014, funding was provided by Cancer Care Ontario to fund an expanded Phase II Pilot
evaluation of EPIC-CP
• EPIC-CP was implemented in four cancer centres across Ontario:
• Princess Margaret Cancer Centre
• Cancer Centre of South Eastern Ontario
• Carlo Fidani Peel Regional Cancer Centre
• Grand River Regional Cancer Centre
• EPIC-CP was implemented in consult and follow-up clinics in radiation oncology and
surgical oncology, as well as treatment review
• Results were extremely positive, with 90% of patients reporting a favourable experience
with EPIC-CP
![Page 32: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/32.jpg)
EPIC-CP Phase II Pilot - Recommendations
32
1. Implement EPIC-CP across Ontario in surgical and radiation outpatient consult and follow-up clinics, as
well as radiation review clinics.
2. EPIC-CP was superior to ESAS-r in capturing prostate-specific symptoms and treatment impacts for the
early stage prostate population. ESAS-r should not be used concurrently for early stage patients. A system
should be designed through the technology platform that allows prostate patients to be directed to EPIC-CP
in place of ESAS-r.
3. Review and adapt (if necessary) clinic flow processes to integrate EPIC-CP into practice and facilitate its
uptake for routine use.
4. Develop training and resources for patients and clinicians that facilitate the interpretation of Patient-
Reported Outcome Measures (PROMs) and improve comfort with completing PROMs using technology.
![Page 33: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/33.jpg)
EPIC (Your Symptoms Matter – Prostate Cancer)
33
April 2017
Wave 1 • Grand River • Trillium • Kingston
October 2016
Wave 2 • PMCC
January 2017
Phase 1
August 2017 October 2017
Phase 2
Wave 3 • London • RVH • JCC • Southlake • Ottawa
Wave 4 • Odette • Lakeridge • Windsor • Sudbury • Thunder Bay
• Official launch date was in October
• New patient, provider, and volunteer resources
• Includes new Symptom Management Guides for patients and providers
• Implementation package
• Detailed resource, customizable to each region to prepare sites for launch
• Community of Practice
• Opportunity for sites within wave to share information and lessons learned
• Sites preparing to launch in next wave will join the CoP a month before go-live
• Resources solicited input from 95 multidisciplinary representatives and informed the
development of 21 training materials
• Community urology
![Page 34: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/34.jpg)
![Page 35: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/35.jpg)
![Page 36: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/36.jpg)
![Page 37: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/37.jpg)
• 8 centres are live
• 7 to follow in upcoming 4-6
months
• ~7000 assessments collected
• Plans to move into
community urology
![Page 38: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/38.jpg)
Future world of PROs in Ontario
Better patient care
Higher quality system
• Patients will have symptoms addressed in
clinic with a standardized approach
• Symptoms that may have been
avoided/missed will be discussed more
commonly
• Patients will be able to view their own
symptoms over time and compare
themselves with patients like them
• We will have PRO data that is reflective of
cancer symptoms and treatment toxicity
across province which will be a strong driver
of quality improvement
![Page 39: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/39.jpg)
39
How is this program driving
quality?
![Page 40: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/40.jpg)
Performance Measurement
40
Each regional cancer centre is
evaluated on many
performance indicators on a
quarterly basis
Compared to their own
historical performance and the
province as a whole
Centre A
Province
Centre B
Province
= # of cancer patients screened with ESAS at least once in a given month
# of cancer patients eligible for symptom screening in a given month
![Page 41: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/41.jpg)
Public Reporting
41 www.csqi.on.ca
![Page 42: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/42.jpg)
Public Reporting
42
![Page 43: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/43.jpg)
Public reporting
43
![Page 44: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/44.jpg)
Chart Audits
44
![Page 45: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/45.jpg)
Chart Audits
45
![Page 46: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/46.jpg)
Better supports
46
![Page 47: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/47.jpg)
47
What have we learned from
ESAS data?
![Page 48: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/48.jpg)
CSQI Index: 2013 CCO Rating
Symptom burden in cancer
![Page 49: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/49.jpg)
Seow, Barbera 2011,
JCO 29 (9) 1151
![Page 50: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/50.jpg)
Seow, Barbera 2011, JCO 29 (9) 1151
![Page 51: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/51.jpg)
Outcomes from High Symptom Burden
51
Odds Ratio of Visiting an ER within 7 Days of an ESAS Assessment by Symptom Severity
Source: Barbera et al, 2012, Ann Emerg Med; 61(4):427-437
![Page 52: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/52.jpg)
52 Seow 2012 Journal Oncology Practice
![Page 53: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/53.jpg)
Opioid use in cancer patients with pain
Search for opioid prescriptions in provincial formulary database
Barbera et al, 2012, JCO 20(10): 1095-1099
![Page 54: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/54.jpg)
Barbera et al, 2012, JCO 20(10): 1095-1099
![Page 55: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/55.jpg)
Observed proportion of patients with a prescription within -30
days to +7 days of index date, by pain severity and year
55
Pain severity
None Mild Moderate Severe Overall
2007 11.5 25.0 41.8 60.9 31.7
2008 9.0 19.9 38.0 52.8 23.7
2009 7.5 15.6 29.6 46.7 18.2
2010 6.2 13.8 27.6 45.4 16.1
2011 5.6 11.7 26.2 42.7 14.8
2012 5.4 11.7 25.4 42.6 14.5
2013 4.9 11.7 25.0 39.2 13.6
Barbera et al, 2017, JOP, in press
![Page 56: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/56.jpg)
• to evaluate the impact of screening with ESAS through OCSMC on ED visit rates in women with breast cancer receiving adjuvant chemotherapy
Objective
• that when women are screened with ESAS as part of the screening program, they would experience fewer ED visits, presumably on the basis of improved symptom control
Hypothesis
Barbera 2015, Support Care Cancer 23(10) 3025
Did routine ESAS symptom screening decrease ED visits
in breast cancer patients on adjuvant chemotherapy?
• RCTs have demonstrated improved patient satisfaction and communication
• Being adopted by many large centres
• In breast cancer many regimens are toxic and high rates of ED visits have
been reported (42-60%)
![Page 57: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/57.jpg)
Method
Recurrent event model
Inclusion criteria
Adult
Stage I-III Breast cancer
2007-2009
On adjuvant chemotherapy
Control for
• Age
• stage
• comorbidity
• chemo regimen
• neighbourhood income
• region
• total number of clinic visits
Exposure
ESAS
Outcome
ED visits
Barbera 2015, Support Care Cancer 23(10) 3025
![Page 58: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/58.jpg)
58
• The rate of ED
visits was 43%
lower among
women screened
with ESAS
compared to those
who were not
• Each additional
ESAS assessment
decreased the ED
visit rate by 17%.
Source: Barbera et al, 2015 Support Care Cancer
Screening with ESAS decreases ED visits
![Page 59: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/59.jpg)
59
Limitations of the data
• Repeated measures, but do not occur at set times
• Almost exclusively in the ambulatory setting
• Not every patient reports on every visit, bias probably exists, but direction
could be either way
Future research directions
• Opioid prescribing in long term survivors
• Impact of screening program on service use
• Symptom profiles by disease type, stage, treatment
• Implication of missing data and inconsistent data timing on using ESAS as
an outcome measurement
![Page 60: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/60.jpg)
Conclusions
60
PROs represent a paradigm shifting approach to facilitate patient centred care
• They can be used at the bedside to identify problems, trigger discussions and help prioritize certain areas
• At a population level they have administrative and policy applications
PROs are embedded within CCO’s strategic planning
Future vision to have all patients screened with generic and disease specific measure
Data available has been used to understand symptom burden, how it predicts for service use
Need to understand how to use this data better as an outcome
![Page 61: Patient Reported Outcomes at Cancer Care Ontario: The ...](https://reader034.fdocuments.us/reader034/viewer/2022050123/626d7460f4bb6035a3412599/html5/thumbnails/61.jpg)
61